XML 25 R38.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Acquisitions (Purchase Price Allocation To Assets Acquired And Liabilities Assumed) (Details) (USD $)
In Thousands
Jun. 30, 2011
Taligen Therapeutics, Inc [Member]
 
Cash and cash equivalents $ 2,678
Other assets 555
Assets acquired 67,733
Deferred tax liability (net) (9,567)
Other liabilities assumed (1,084)
Liabilities assumed (10,651)
Goodwill 60,066
Total purchase price 117,148
Taligen Therapeutics, Inc [Member] | In-process Research and Development [Member]
 
Non-amortizable intangible assets 59,500
Orphatec Pharmaceuticals GmbH [Member]
 
Other assets 73
Assets acquired 8,123
Goodwill 13
Total purchase price 8,136
Orphatec Pharmaceuticals GmbH [Member] | In-process Research and Development [Member]
 
Non-amortizable intangible assets $ 8,050